Literature DB >> 6136856

Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease.

E W Gelfand, D McCurdy, C P Rao, P J Middleton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6136856     DOI： 10.1016/s0140-6736(83)92265-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed.

Authors:  D Isaacs; E R Moxon; D Harvey; I Kovar; C R Madeley; R J Richardson; M Levin; A Whitelaw; N Modi
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 2.  Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Authors:  N J Snell
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Antiviral therapy with small particle aerosols.

Authors:  V Knight; B Gilbert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

Review 4.  Biochemistry and clinical applications of ribavirin.

Authors:  B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

5.  Pharmacokinetics of ribavirin aerosol in mice.

Authors:  B E Gilbert; P R Wyde
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.

Authors:  S Z Wilson; B E Gilbert; J M Quarles; V Knight; H W McClung; R V Moore; R B Couch
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

Review 7.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

Review 8.  Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

9.  Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol.

Authors:  P R Wyde; S Z Wilson; B E Gilbert; R H Smith
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

10.  Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay.

Authors:  R A Karron; J L Froehlich; L Bobo; R B Belshe; R H Yolken
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.